ReviewPharmaceutics2022

Nanotechnology-Based Combinatorial Anti-Glioblastoma Therapies: Moving from Terminal to Treatable.

Amir Barzegar Behrooz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.